Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Titel:
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Auteur:
Shaw, Alice T Felip, Enriqueta Bauer, Todd M Besse, Benjamin Navarro, Alejandro Postel-Vinay, Sophie Gainor, Justin F Johnson, Melissa Dietrich, Jorg James, Leonard P Clancy, Jill S Chen, Joseph Martini, Jean-François Abbattista, Antonello Solomon, Benjamin J